INTRODUCTION
Scott, Bradley and Timm first described the use of an artificial urinary sphincter in 1973. Since then there have been four major modifications (Montague 1981) . The current model is now used extensively. All patients in this series were implanted with the latest model, the American Medical Systems sphincter 800 ( fig. 1 ). This consists of a balloon, a cuff and a control pump connected by tubing. The cuff surrounds the urethra either at the bladder neck or the membranous urethra (figs 2 and 3). The cuff when inflated compresses the urethra maintaining continence. If the patient wishes to micturate he/she squeezes the control pump which is situated in the scrotum or labia. This pumps fluid from the cuff to the balloon reservoir thus deflating the cuff and allowing micturition. The cuff refills automatically over a few minutes. The AMS 800 also has a deactivation button on the control pump which prevents fluid returning from the balloon to the cuff. They fell into two groups, one with 'congenital' causes for their incontinence and the other with 'acquired' causes. 21 patients belonged to the 'congenital' group. 17 of these patients had spina bifida of differing degrees of severity. 2 patients had sacral Iipomata and 2 had sacral agenesis. 10 patients belonged to the 'acquired' group. 6 of these were incontinent following prostatectomy (4 transurethral and 2 retropubic prostatectomy). 1 was incontinent following radiotherapy for prostatic carcinoma and 3 following trauma due to road traffic accidents. Of these, all but one was neurologically normal.
The patients from the 'congenital' groups spanned an age range from 11-32. 7 patients were female and 14 male. The patients from the 'acquired' groups were all male and spanned an age range from 38-83 years.
SELECTION CRITERIA
Patients were chosen for artificial sphincter implantation after careful assessment. Patients were referred from both inside the health authority and from further away. All patients were seen for full assessment at the Urodynamic Unit at Ham Green Hospital. They underwent a full history and examination followed by urodynamic studies. These comprised filling and voiding video cystometry, and urethral pressure profiles.
The following criteria were used for selection:-(a) Motivation All patients appeared well motivated. The procedures and extent of the surgery was fully explained. In the 'congenital' Figure 1 The AMS 800 Artificial Urinary Sphincter AMS 800 Sphincter with cuff around the bulbous urethra in a male patient (cuff inserted via perineal approach). Vesico ureteric reflex was noted in several cases. In the 'congenital' groups all but 2 patients had features of detrusor instability. 4 patients were commenced on anticholinergics, and follow up urodynamics showed improvement. All had demonstrable stress incontinence and abnormal urethral pressures. Capacity ranged from 30-625 ml. but only 3 patients had a capacity below 200 ml. 3 of this group had ileal conduits and 1 had had an undiversion two years previously. In the 'acquired group' 6 patients had stable bladders and 4 had some features of instability. All had stress incontinence and abnormally low urethral pressure profile (U.P.P.) Capacity ranged from 250 to 600 ml. Bladder neck sphincters were inserted in two ways. In most male patients (13) the cuff was placed around the urethra, above the pelvic floor but below the prostate, after division of the pubo-prostatic and pubo-urethral ligaments. When this was not possible the cuff was placed at the bladder neck, leaving the vasa and seminal vesicals posterior to the cuff.
In female patients the cuff was placed around the bladder neck and proximal urethra. In order to minimise the risk of erosion, in all recent patients, the cuff has been 'sandwiched' between two layers of omentum, having previously mobilised the omentum from the transverse colon.
If bladder augmentation (see below) was not performed, then the balloon and pump were also implanted at the primary procedure. The patient was then sent home for six weeks prior to activation of the sphincter.
The AMS 800 sphincter can be de-activated when the pump is inserted, by pressure on the valve mechanism within the pump. Once all post-operative swelling has settled the patient can then be readmitted for sphincter activation, achieved by firm pressure on the pump, via the skin.
Bladder Augmentation
When bladder capacity, bladder compliance or detrusor instability were significant problems the bladder was augmented. A variety of techniques was used. Where possible the ileum was used having split the bladder from ureteric orifice to ureteric orifice. The smaller the capacity, the greater the length of ileum used. The ileum was open fully, along its antimesenteric border, prior to its being sewn into the opened bladder. When augmentation was performed, then the balloon and pump were inserted at a second operation six weeks after the insertion of cuff and bladder augmentation. It was felt that this delay would reduce the risk of sphincter infection. Furthermore in some female patients the cuff was sufficient to make the patient continent.
None of the 'acquired' group underwent bladder augmentation, but 10 of the 'congenital' group underwent either an ileo or caeco-cystoplasty. In the 3 patients with ileal conduits, these were incorporated into the bladder during augmentation.
RESULTS (a) Perineal Sphincters
Of the 10 patients 6 were completely dry, 1 was damp, but improved on anticholinergics, and 2 were damp needing 1-2 pads per day which was still a marked improvement on their pre-operative condition. 1 patient remained wet and will be considered with the complications. 
